{
    "nctId": "NCT02940912",
    "officialTitle": "Double Bind Randomized Placebo-controlled Cross-over Study to Evaluate Effect of Continuous Apomorphine During the Night on Sleep Disorders in Insomniac Patients With Parkinson's Disease",
    "inclusionCriteria": "* Idiopathic Parkinson's disease ( Hughes AJ et al. 2001)\n* Patients with motor fluctuations\n* Chronic Insomnia disorder criteria according to the criteria of DMS- V ( American Psychiatric Association, 2013) and insomnia severity index \\> 15\n* Able to use independently the device required for treatment by apomorphine\n* Collection of written informed consent (legal obligation for any project under the public health law , bioethics laws and / or CNIL) .\n* Affiliate to social security or beneficiary of such a regime\n* Must have minimum age of 35 Years\n* Must have maximum age of 90 Years",
    "exclusionCriteria": "* Atypical Parkinsonian Syndromes\n* Parkinson's disease with dementia (Montreal Cognitive Assessment (MoCA) \\<25/30 (NASREDDINE and al., 2012))\n\n  * Parkinson's disease with hallucinations\n  * Parkinson's disease with impulse Control disorder (ICD)\n  * Parkinson's disease already treated with APOMORPHINE pump or justifying the use of the pump continuously day and night\n  * Another obvious severe disease explaining insomnia\n  * Exclusion for monitoring difficulties (mutation, insufficient motivation, priority associated pathology in care)\n  * Patient unwilling to accept a pump\n  * Patient not accepting polysomnography and multiple sleep latency test\n  * Patient with health problems or a skin disease precluding continuous subcutaneous infusion\n  * Female parturient or nursing\n  * Cardiac dysrhythmia precluding treatment with domperidone or apomorphine (increased QTc \u2265 440 ms in men, QTc \u2265 450 ms in women)\n  * Treatments forbidden in association with apomorphine such as:\n\n    * antiemetic neuroleptics\n    * Tetrabenazine\n  * Excessive alcohol consumption\n  * Contraindications for apomorphine:\n\n    * Hypersensitivity to apomorphine or one of the excipients\n    * Respiratory Depression\n    * Hepatic impairment\n    * Intellectual Disability\n    * Dementia"
}